Public Health

Population health, policy and the data behind prevention.

MHRA variation rules tighten for UK medicines from 2026

MHRA updates UK medicines variation guidance for 2026, including new Type IA, IB and II procedures, annual update rules and approval pathways.

MHRA sets out a 2030 strategy to speed safe access to medicines, expand AI oversight, strengthen real-world evidence…

MHRA guidance details UK GLP membership, inspection cycles, deficiency grading, fees, and enforcement for safety test facilities.

WHO Youth Council opened its 2026–2028 term in Berlin, setting priorities on youth leadership, equity, health literacy and…

WHO is inviting organizations to join a new global movement linking science, policy and communication to strengthen trust…

WHO has released a toolkit to improve tuberculosis research in pregnancy and lactation, addressing major safety and dosing…

WHO and partners reported progress on NTD supply chains, including faster customs clearance, stronger forecasting and more country-led…

A cross-sectional survey in the U.S. examines children’s health before, during, and after parental or caregiver immigration detention.

German universities and research organizations spent €9.6 million on open access fees over a decade, with most articles…

CMAJ outlines its publication priorities, editorial standards, and embargo policies as it focuses on access to health care…

Public Health

Population health, policy and the data behind prevention.

In Brief The 5-minute rounds